Barclays’s Cue Biopharma CUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4K Hold
6,029
﹤0.01% 4229
2025
Q1
$5K Hold
6,029
﹤0.01% 4202
2024
Q4
$7K Hold
6,029
﹤0.01% 4214
2024
Q3
$5K Sell
6,029
-12,269
-67% -$10.2K ﹤0.01% 4188
2024
Q2
$22K Sell
18,298
-13,106
-42% -$15.8K ﹤0.01% 3884
2024
Q1
$59K Sell
31,404
-24,125
-43% -$45.3K ﹤0.01% 3782
2023
Q4
$146K Buy
55,529
+43,516
+362% +$114K ﹤0.01% 3616
2023
Q3
$28K Sell
12,013
-933
-7% -$2.18K ﹤0.01% 3803
2023
Q2
$48K Buy
12,946
+6,917
+115% +$25.6K ﹤0.01% 3688
2023
Q1
$22K Hold
6,029
﹤0.01% 3975
2022
Q4
$17K Sell
6,029
-159
-3% -$448 ﹤0.01% 4052
2022
Q3
$14K Sell
6,188
-1,026
-14% -$2.32K ﹤0.01% 4055
2022
Q2
$18K Sell
7,214
-4,997
-41% -$12.5K ﹤0.01% 4134
2022
Q1
$60K Sell
12,211
-32,210
-73% -$158K ﹤0.01% 3924
2021
Q4
$503K Buy
44,421
+24,636
+125% +$279K ﹤0.01% 2528
2021
Q3
$288K Buy
19,785
+14,153
+251% +$206K ﹤0.01% 2821
2021
Q2
$66K Sell
5,632
-19,098
-77% -$224K ﹤0.01% 3283
2021
Q1
$302K Buy
24,730
+11,388
+85% +$139K ﹤0.01% 2938
2020
Q4
$166K Sell
13,342
-5,686
-30% -$70.7K ﹤0.01% 2779
2020
Q3
$286K Buy
19,028
+3,481
+22% +$52.3K ﹤0.01% 2567
2020
Q2
$381K Buy
15,547
+8,875
+133% +$217K ﹤0.01% 2482
2020
Q1
$94K Sell
6,672
-13,285
-67% -$187K ﹤0.01% 2853
2019
Q4
$317K Buy
19,957
+5,722
+40% +$90.9K ﹤0.01% 2941
2019
Q3
$120K Buy
14,235
+2,603
+22% +$21.9K ﹤0.01% 3306
2019
Q2
$105K Buy
11,632
+6,496
+126% +$58.6K ﹤0.01% 3563
2019
Q1
$40K Buy
+5,136
New +$40K ﹤0.01% 3734
2018
Q4
Sell
-6,628
Closed -$60K 4137
2018
Q3
$60K Buy
6,628
+5,334
+412% +$48.3K ﹤0.01% 3671
2018
Q2
$15K Sell
1,294
-549
-30% -$6.36K ﹤0.01% 3747
2018
Q1
$26K Buy
+1,843
New +$26K ﹤0.01% 3768